Analyst Price Targets — CVS
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 14, 2026 11:49 am | David MacDonald | Truist Financial | $118.00 | $105.90 | TheFly | CVS Health price target raised to $118 from $108 at Truist |
| July 13, 2026 11:05 am | — | Wells Fargo | $123.00 | $104.15 | TheFly | CVS Health price target raised to $123 from $103 at Wells Fargo |
| July 9, 2026 12:12 pm | — | RBC Capital | $113.00 | $104.83 | TheFly | CVS Health price target raised to $113 from $107 at RBC Capital |
| July 7, 2026 11:23 am | — | Cantor Fitzgerald | $110.00 | $102.08 | StreetInsider | CVS Health (CVS) PT Raised to $110 at Cantor Fitzgerald Post ChecksMember Login |
| July 6, 2026 2:21 pm | — | HSBC | $103.00 | $102.28 | TheFly | CVS Health price target raised to $103 from $85 at HSBC |
| June 8, 2026 11:26 am | — | Mizuho Securities | $115.00 | $95.93 | TheFly | CVS Health price target raised to $115 from $110 at Mizuho |
| June 4, 2026 11:50 am | — | Morgan Stanley | $111.00 | $91.37 | TheFly | CVS Health price target raised to $111 from $106 at Morgan Stanley |
| June 1, 2026 11:26 am | — | Truist Financial | $108.00 | $90.98 | TheFly | CVS Health price target raised to $108 from $102 at Truist |
| June 1, 2026 10:54 am | Jessica Tassan | Piper Sandler | $113.00 | $90.98 | StreetInsider | Piper Sandler Reiterates Overweight Rating on CVS Health (CVS) |
| May 26, 2026 12:57 pm | Andrew Mok | Barclays | $106.00 | $91.63 | TheFly | CVS Health price target raised to $106 from $101 at Barclays |
Latest News for CVS
Pharmacy-focused sites to open in select communities to help increase access to pharmacy care Openings are part of ongoing commitment to serve communities and meet consumers where they are WOONSOCKET, R.I., July 17, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) today unveiled its first pharmacy-focused CVS Pharmacy® in Houston.
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
CVS Health (CVS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Providers give a 6.1 payer trust score, up from 5.4 in the previous study Providers weigh in on the potential of technology-enabled solutions to reduce administrative burden and save valuable time HARTFORD, CT, July 15, 2026 /PRNewswire/ -- Aetna®, a CVS Health® company (NYSE: CVS) today announced findings from the second Aetna Provider Survey. The Aetna Provider Survey is a quarterly study that polls the U.S.…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.